Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

Breakthroughs, discoveries, and DIY tips sent six days a week. Terms of Service and Privacy Policy. Apple Notes is available to you if you buy an iPhone, iPad, or Mac ...

Arkansas is changing fast, and we’re here to help you make sense of it. Sign up today and receive the news that's important to you straight to your inbox. We’re here to hold power accountable, but we ...

Google’s NotebookLM is experimenting with a feature that could make studying feel a lot more like attending an actual class. A new Lecture mode can turn your uploaded notes, documents, and sources ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

This is read by an automated voice. Please report any issues or inconsistencies here. On a nippy Monday night at the Zebulon in Frogtown, a man wearing a Jason Voorhees T-shirt steps onto a ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Chicago Med is currently on winter break after the fall finale in the 2025 TV schedule, but will return early in the 2026 TV schedule to pay off on the dangerous cliffhanger. While Lenox is the ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...